EUVIMEDEUVIMED entdecken
Fallbericht

Sequential BV‐AVD Therapy in Richter Transformation: Insights Into the Management of Elderly Patients

Arianna Bevilacqua, Alessandro Cellini, Nicolò Danesin, Francesco Angotzi, Andrea Serafin, Giovanni Leone iD, Mattia D'Antiga, Francesco Piazza iD, Marco Pizzi, Livio Trentin, Andrea Visentin

Hematological Oncology · 2026-05 · 44 (3)

DOI: 10.1002/hon.70197 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Hematological Oncology, online erschienen am 13.05.2026. Verfasst von Arianna Bevilacqua und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hematology Unit, Department of Medicine, University of Padova, Padua, Italy. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Hodgkin Disease, Leukemia, Lymphocytic, Chronic, B-Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Gefördert von: Associazione Italiana per la Ricerca sul Cancro, Progetti di Rilevanza Nazionale PRIN PNRR, Ricerca per Credere nella Vita odv.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hodgkin‐variant Richter's transformation (HvRT) is a rare evolution of chronic lymphocytic leukemia (CLL) into a lymphoma with histological characteristics akin to those of classical Hodgkin lymphoma (cHL), overall occurring in < 1% of CLL cases. Due to its rarity, treatment is not standardized and is commonly adapted from cHL regimens, although toxicity limits their use in older or heavily pretreated patients. We describe two cases of HvRT treated with a modified sequential brentuximab vedotin‐AVD‐brentuximab vedotin (BV‐AVD‐BV) regimen, previously explored in elderly patients with cHL. Sequential BV‐AVD‐BV was feasible and manageable in both cases, with acceptable hematologic toxicity. One patient achieved a durable complete metabolic remission, while the other required immune checkpoint inhibitor‐based salvage therapy followed by autologous stem cell transplantation, resulting in complete metabolic response. These cases suggest that sequential BV‐AVD‐BV may represent a tolerable and effective therapeutic option for selected patients with HvRT. Incorporation of modern Hodgkin‐directed strategies, including sequential regimens and immune checkpoint inhibitors, warrants further evaluation in this rare clinical setting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsHodgkin DiseaseLeukemia, Lymphocytic, Chronic, B-CellAgedFemaleHumansMaleBrentuximab VedotinCell Transformation, Neoplastic

Substanzen

Brentuximab Vedotin

Autor:innen und Institutionen

  • Hematology Unit, Department of Medicine, University of Padova, Padua, Italy.
  • Surgical Pathology and Cytopathology Unit, Department of Medicine, University of Padova, Padua, Italy.

ORCID-Profile: Giovanni Leone, Francesco Piazza

Förderung

  • Associazione Italiana per la Ricerca sul Cancro
  • Progetti di Rilevanza Nazionale PRIN PNRR
  • Ricerca per Credere nella Vita odv
  • Supporting Talent in ReSearch@University of Padua

Zitieren

APA

Bevilacqua, A., Cellini, A., Danesin, N., Angotzi, F., Serafin, A., Leone, G., D'Antiga, M., Piazza, F., Pizzi, M., Trentin, L., & Visentin, A. (2026). Sequential BV‐AVD Therapy in Richter Transformation: Insights Into the Management of Elderly Patients. Hematological Oncology, 44(3). https://doi.org/10.1002/hon.70197

Vancouver

Bevilacqua A, Cellini A, Danesin N, Angotzi F, Serafin A, Leone G, et al. Sequential BV‐AVD Therapy in Richter Transformation: Insights Into the Management of Elderly Patients. Hematological Oncology. 2026;44(3). doi:10.1002/hon.70197

BibTeX
@article{Bevilacqua2026,
  author = {Bevilacqua, Arianna and Cellini, Alessandro and Danesin, Nicolò and Angotzi, Francesco and Serafin, Andrea and Leone, Giovanni and D'Antiga, Mattia and Piazza, Francesco and Pizzi, Marco and Trentin, Livio and Visentin, Andrea},
  title = {Sequential BV‐AVD Therapy in Richter Transformation: Insights Into the Management of Elderly Patients},
  journal = {Hematological Oncology},
  year = {2026},
  volume = {44},
  number = {3},
  doi = {10.1002/hon.70197}
}
Kostenlos starten →